Choose Language:


Trust in our CNAP® technology for more than 20 years

Syncope ManagemenT

“We have used the Task Force® Monitor in our Falls and Syncope Service for 8 years and have 7 machines operational in our unit. We use the TFM for the investigation of syncope, orthostatic hypotension and autonomic function tests and find the monitors very user friendly. We have found both the service and support exceptional. Both the distributors and the manufacturers have always been easy to contact, and have also provided a personal touch to their service. We use the equipment for clinical and research purposes, and are highly satisfied with the data obtainable from the Task Force® Monitor, as much of the analysis is automated and the information can be transported to a wide range of software applications. We as a department are very happy with the Task Force Monitors.”

Pam Reeve, Syncope Unit, Royal Victoria Infirmary Newscastle, UK

Play Video

Prof. Falko Skrabal, Syncope Assessment with TFM, Medical University Graz, Graz, Austria

Autonomic Function

“The Task Force® Monitor has revolutionized ease-of-use in performing and generating data both for research and clinical purposes. I am especially impressed with the amount of information gathered. As a clinical fellow at the NYU Dysautonomia Center I did comparative analysis using this equipment to look at cardiac output and stroke volume and found it to be quite accurate. And the report generated is very informative.”

Ishan Adhikari, MD., University of Texas Health Science Center, San Antonio, Texas, USA


“We chose the Task Force® Monitor for a large, multi-center NIH study due to its ability to collect beat-to-beat data for heart rate, blood pressure, and baroreceptor sensitivity using novel, non-invasive technology. In addition to it’s ease of use, we have been pleased with both the data quality and the ability to easily export data.”

Jeffrey Olgin, M.D., Chief of Cardiology, University of California, San Francisco, USA


Play Video

DDr. Michael Trapp, Dpt. of Medical Psychology and Psychotherapy, University Hospital Graz, Austria


“I think the CNAP® is great device. I have had extensive experience using the Ohmeda 2300 and the Finometer. I will continue to use our CNAP® devices in more controlled acute studies because of its ease of use and accuracy. We are also very appreciative of the support from CNSystems and Partners in Medicine.”

Jan Berkow, Chief Technology Officer, Intelomed Inc., USA

“Last year we replaced our Colin Pilot units with CNAP® Monitors. They are being used as part of a longitudinal study that includes measurement of changes in blood pressure over time in young, middle-aged, and older adults. The CNAP® Monitors have performed reliably and are well tolerated by our subjects.”

Louise Hawkley, PhD, Associate Director, The Social Neuroscience Laboratory, University of Chicago, USA


Play Video

Dr. Andreas Rössler, Dpt. of Physiology, Medical University Graz, Austria

Fluid Management

“Hemodynamic Monitoring with CNAP® and PPV should extend the positive outcome of goal-directed fluid management beyond high-risk, arterial-line managementor Doppler-monitored surgeries. This would allow fluid management to become an actual clinical standard for the benefit of patients.”

Prof. Bennoit Vallet, MD, PhD, University Hospital Lille, France


“The CNAP® technology enables advanced hemodynamic monitoring even in medium-risk patients and procedures in a fast, easy and noninvasive way.”

Prof. Dr. med. Berthold Bein, Anesthesiology and Intensive Care, Asklepios Clinic St. Georg, Hamburg, Germany

“This device, the CNAP®, has all the features of a disruptive technology.[…] It is only a matter of time until volume clamp devices replace many if not the majority of arterial catheters for the continuous measurement of blood pressure, arterial respiratory variation, and even noninvasive cardiac output monitoring.”

Robert H. Thiele, MD, Dpt. of Anesthesia, University of Virginia, USA.

“We just started to use your monitor on high risk orthopedic and bariatric patients at our hospital in Geneva. It is marvellous and a great tool for anesthesia!!”

John Diaper, PhD, Dpt. of Anesthesiology, Pharmacology and Intensive Care, University Hospital Geneva, Switzerland

“CNAP® enables easy-to-apply noninvasive continuous blood pressure measurement allowing for closer blood pressure management during anesthesia and avoids the general risks of an arterial measurement. This provides advantages for patients with difficult vascular status and puncture, short interventions in patients with cardiovascular comorbidity or restrictive indication for invasive measurement […].”

Prof. Peter Lauven, Anesthesiology & Operative ICU, Bielefeld, Germany

“The CNAP® device detected more hypotensive episodes after spinal anesthesia and significantly lower arterial pressure (AP) compared with NIAP. AP monitoring based on CNAP® may improve haemodynamic management in this patient population with potential benefit for the fetus.” (1)

Dr. Christoph Ilies, Marienhospital, Stuttgart, Germany


“We have been impressed with the CNAP® Monitor and would suggest that it can certainly be used instead of an arterial line in some cases. It would make a great adjunct in any OR case when hemodynamic instability develops unexpectedly and one wants to continuously monitor BP while arterial access is gained.”

Joseph Tobias, M.D., Chief of Anesthesiology, Nationwide Children’s Hospital, Columbus, Ohio, USA

“For anesthesia in elderly patients stable cardiovascular conditions during the entire surgical procedure are essential for a good outcome. For this purpose, close meshed blood pressure monitoring and also enhanced hemodynamic monitoring are very important and increase patient safety. This could just as well apply for extended high risk surgery but also for shorter procedures. Invasive arterial cannulation in elderly patients with systemic arteriosclerosis cannot be applied without certain concerns and could be technically difficult to carry out. Especially in this patient group CNAP® HD is an easy-to- apply, risk-free and reliable method for continuous non-invasive hemodynamic monitoring.”

OA Dr. Günther Sumann, Department of Anaesthesia and Intensive Care, Hospital Bregenz, Austria

“I clearly see the clinical application areas of the CNAP® HD Monitor in all patients at high cardiovascular risk where invasive blood pressure measurement with an arterial line is not necessarily justified due to the length and the severity of the procedure. It also seems useful for the hemodynamic monitoring already before anesthetic induction to avoid unnecessary stress for the patient by placing an arterial catheter.”

Prim. Dr. Alexander Kulier, Head of Dpt. of Anesthesiology, Krankenhaus der Elisabethinen, Linz, Austria

Intensive Care

“In conclusion, in ICU patients, the CNAP® system shows reasonable accuracy and precision for the determination of mean and diastolic AP compared with the criterion standard (invasive arterial catheter.)”

Dr. Julia Nicklas, Center of Anesthesiology and ICU, University Medical Center, Hamburg-Eppendorf, Germany



“The first hours in the emergency department may be crucial for the patient in terms of physical long-term damage or survival. A continuous noninvasive arterial pressure monitoring technology like the CNAP® system might help to increase patient safety.”

Dr. Julia Nicklas, Center of Anesthesiology and ICU, University Medical Center, Hamburg-Eppendorf, Germany



(1) Ilies C, Kiskalt H, Siedenhans D, Meybohm P, Steinfath M, Bein B, Hanss R. Detection of hypotension during Caesarean section with continuous non-invasive arterial pressure device or intermittent oscillometric arterial pressure measurement. Br J Anaesth. 2012 Sep;109(3):413-9. doi: 10.1093/bja/aes224. Epub 2012 Jul 12. PMID: 22798273.